GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Inventories, Other

G.Barekat Pharm (XTEH:BRKT1) Inventories, Other : IRR30,615 Mil (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. G.Barekat Pharm's other inventories for the quarter that ended in Mar. 2017 was IRR30,615 Mil.

G.Barekat Pharm's quarterly other inventories stayed the same from . 20 (IRR0 Mil) to Mar. 2016 (IRR0 Mil) but then increased from Mar. 2016 (IRR0 Mil) to Mar. 2017 (IRR30,615 Mil).

G.Barekat Pharm's annual other inventories stayed the same from . 20 (IRR0 Mil) to Mar. 2016 (IRR0 Mil) but then increased from Mar. 2016 (IRR0 Mil) to Mar. 2017 (IRR30,615 Mil).


G.Barekat Pharm Inventories, Other Historical Data

The historical data trend for G.Barekat Pharm's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Inventories, Other Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Inventories, Other
- 30,615.00

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Inventories, Other - 30,615.00

G.Barekat Pharm Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines